Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorsomradee, S.
Right arrow Articles by De Hert, S. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorsomradee, S.
Right arrow Articles by De Hert, S. G
Asian Cardiovasc Thorac Ann 2008;16:256-264
© 2008 Asia Publishing EXchange Ltd

REVIEW PAPER

Cardioprotection with Volatile Anesthetics in Cardiac Surgery

Suraphong Lorsomradee, MD, Stefanie Cromheecke, MD, Sratwadee Lorsomradee, MD, Stefan G De Hert, MD

Department of Anesthesiology, Academic Medical Center, University of Amsterdam, The Netherlands

For reprint information contact: Stefan G De Hert, MD, Tel: 31 20 566 2533(Secr.), Fax: 31 20 697 9441, Email: S.G.DeHert{at}amc.uva.nl, Department of Anesthesiology, Division of Cardiothoracic and Vascular Anesthesiology, University of Amsterdam, Meibergdreef 9, Postbus 22660 H1Z-115, 1100 DD Amsterdam, The Netherlands.

Myocardial ischemia during the perioperative period is a major cause of morbidity and mortality after surgery. Experimental data indicate that clinical concentrations of volatile anesthetics protect the myocardium from ischemia and reperfusion injury, as shown by decreased infarct size and more rapid postoperative recovery of contractile function. These anesthetics may also mediate protective effects in other organs, such as the brain and kidney. A number of recent reports have indicated that these experimentally observed protective effects might also be present in the clinical setting. Implementation of such cardioprotection during surgery may provide an additional tool in the treatment and prevention of ischemic cardiac dysfunction in the perioperative period. This review discusses the clinical studies that have focused on the potential cardioprotective effects of volatile anesthetic agents.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by SAGE Publications